标题
Therapies currently in Phase II trials for malignant pleural mesothelioma
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 22, Issue 10, Pages 1255-1263
出版商
Informa Healthcare
发表日期
2013-07-02
DOI
10.1517/13543784.2013.816281
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma
- (2017) Marjorie G. Zauderer et al. Journal of the National Comprehensive Cancer Network
- Increased Plasma Colloid Osmotic Pressure Facilitates the Uptake of Therapeutic Macromolecules in a Xenograft Tumor Model
- (2015) Matthias Hofmann et al. NEOPLASIA
- Tremelimumab: a review of development to date in solid tumors
- (2013) Ahmad A Tarhini Immunotherapy
- The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
- (2013) Adina Brett et al. Molecular Cancer
- Activity of the Fibroblast Growth Factor Receptor Inhibitors Dovitinib (TKI258) and NVP-BGJ398 in Human Endometrial Cancer Cells
- (2013) G. E. Konecny et al. MOLECULAR CANCER THERAPEUTICS
- Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma
- (2012) Jaine K. Blayney et al. EUROPEAN JOURNAL OF CANCER
- Anti-angiogenic therapies for malignant pleural mesothelioma
- (2012) Giovanni Luca Ceresoli et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Structural studies of the TGF-βs and their receptors - insights into evolution of the TGF-β superfamily
- (2012) Andrew P. Hinck FEBS LETTERS
- Efficacy of anti-insulin-like growth factor I receptor monoclonal antibody cixutumumab in mesothelioma is highly correlated with insulin growth factor-I receptor sites/cell
- (2012) Neetu Kalra et al. INTERNATIONAL JOURNAL OF CANCER
- Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase II Trial of Gemcitabine/Cisplatin Plus Bevacizumab or Placebo in Patients With Malignant Mesothelioma
- (2012) Hedy L. Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions
- (2012) Kevin J. Curran et al. JOURNAL OF GENE MEDICINE
- Zoledronic Acid Produces Antitumor Effects on Mesothelioma Through Apoptosis and S-Phase Arrest in p53-Independent and Ras prenylation-Independent Manners
- (2012) Shinya Okamoto et al. Journal of Thoracic Oncology
- Immunotherapies for non-small-cell lung cancer and mesothelioma
- (2012) Anish Thomas et al. LANCET ONCOLOGY
- Overexpression and potential targeting of the oncofoetal antigen 5T4 in malignant pleural mesothelioma
- (2012) Saly Al-Taei et al. LUNG CANCER
- Perifosine as a Potential Novel Anti-Cancer Agent Inhibits EGFR/MET-AKT Axis in Malignant Pleural Mesothelioma
- (2012) Giulia Pinton et al. PLoS One
- Novel Recombinant Alphaviral and Adenoviral Vectors for Cancer Immunotherapy
- (2012) Takuya Osada et al. SEMINARS IN ONCOLOGY
- ALK1 as an emerging target for antiangiogenic therapy of cancer
- (2011) S. I. Cunha et al. BLOOD
- Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies
- (2011) Dana D. Hu-Lowe et al. CANCER RESEARCH
- Phase I/II and Pharmacodynamic Study of Dovitinib (TKI258), an Inhibitor of Fibroblast Growth Factor Receptors and VEGF Receptors, in Patients with Advanced Melanoma
- (2011) K. B. Kim et al. CLINICAL CANCER RESEARCH
- TroVax, a recombinant modified vaccinia Ankara virus encoding 5T4: Lessons learned and future development
- (2011) Dae Won Kim et al. Human vaccines & immunotherapeutics
- TroVax®vaccine therapy for renal cell carcinoma
- (2011) Rui-Tao Zhang et al. Immunotherapy
- Phase II Study of Cediranib in Patients with Malignant Pleural Mesothelioma: SWOG S0509
- (2011) Linda L. Garland et al. Journal of Thoracic Oncology
- Germline BAP1 mutations predispose to malignant mesothelioma
- (2011) Joseph R Testa et al. NATURE GENETICS
- Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant Mesothelioma
- (2010) Joost P. Hegmans et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer
- (2010) Lee M. Krug et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase II Study of Asparagine-Glycine-Arginine–Human Tumor Necrosis Factor α, a Selective Vascular Targeting Agent, in Previously Treated Patients With Malignant Pleural Mesothelioma
- (2010) Vanesa Gregorc et al. JOURNAL OF CLINICAL ONCOLOGY
- Estrogen Receptor β Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib
- (2010) Giulia Pinton et al. PLoS One
- Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation
- (2010) Haining Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Studies With Anti–CTLA-4 Antibodies in Non-melanoma Indications
- (2010) Luana Calabrò et al. SEMINARS IN ONCOLOGY
- Phase Ib study of NGR–hTNF, a selective vascular targeting agent, administered at low doses in combination with doxorubicin to patients with advanced solid tumours
- (2009) V Gregorc et al. BRITISH JOURNAL OF CANCER
- Inhibition of the insulin-like growth factor 1 receptor pathway enhances the antitumor effect of cisplatin in human malignant mesothelioma cell lines
- (2009) Kiyonori Kai et al. CANCER LETTERS
- Estrogen Receptor- Affects the Prognosis of Human Malignant Mesothelioma
- (2009) G. Pinton et al. CANCER RESEARCH
- Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cells
- (2009) Koji Kawaguchi et al. CARCINOGENESIS
- Malignant Pleural Mesothelioma
- (2009) Mandira Ray et al. CHEST
- Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeons for the management of malignant pleural mesothelioma
- (2009) A. Scherpereel et al. EUROPEAN RESPIRATORY JOURNAL
- Cixutumumab
- (2009) Kevin P McKian et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- TGF-β signaling in vascular biology and dysfunction
- (2008) Marie-José Goumans et al. CELL RESEARCH
- Genetic susceptibility to malignant mesothelioma and exposure to asbestos: The influence of the familial factor
- (2007) Donatella Ugolini et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started